Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer

This cohort study examines the association of KRAS status with outcomes following immune checkpoint inhibition monotherapy vs chemoimmunotherapy.

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Sun, Lova, Hsu, Miles, Cohen, Roger B., Langer, Corey J., Mamtani, Ronac, Aggarwal, Charu
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2021
Assuntos:
Research Letter
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8050787/
https://ncbi.nlm.nih.gov/pubmed/33856403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2021.0546
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados